Thomas Desrosier - Net Worth and Insider Trading
Thomas Desrosier Net Worth
The estimated net worth of Thomas Desrosier is at least $114,143 dollars as of 2025-01-13. Thomas Desrosier is the Chief Legal Officer and EVP of Seres Therapeutics Inc and owns about 135,192 shares of Seres Therapeutics Inc (MCRB) stock worth over $114,143. Details can be seen in Thomas Desrosier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Desrosier has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Desrosier
Thomas Desrosier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Desrosier owns 2 companies in total, including Seres Therapeutics Inc (MCRB) , and ARIAD Pharmaceuticals Inc (ARIA) .
Click here to see the complete history of Thomas Desrosier’s form 4 insider trades.
Insider Ownership Summary of Thomas Desrosier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-11-18 | See Remarks |
| ARIA | ARIAD Pharmaceuticals Inc | 2016-03-07 | EVP & General Counsel |
Thomas Desrosier Latest Holdings Summary
Thomas Desrosier currently owns a total of 1 stock. Thomas Desrosier owns 135,192 shares of Seres Therapeutics Inc (MCRB) as of November 18, 2024, with a value of $114,143.
Latest Holdings of Thomas Desrosier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-11-18 | 135,192 | 0.84 | 114,143 |
Holding Weightings of Thomas Desrosier
Thomas Desrosier Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Desrosier has made a total of 6 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Seres Therapeutics Inc is the sale of 878 shares on November 18, 2024, which brought Thomas Desrosier around $474.
Insider Trading History of Thomas Desrosier
- 1
Thomas Desrosier Trading Performance
Thomas Desrosier Ownership Network
Ownership Network List of Thomas Desrosier
Ownership Network Relation of Thomas Desrosier
Thomas Desrosier Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
Thomas Desrosier is the See Remarks of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and See Remarks Moltke Lisa Von .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, Thomas Desrosier made 6 insider transaction in Seres Therapeutics Inc (MCRB) with a net sale of 14,948. Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 35,910 shares made by Teresa L. Young , a net sale of 36,307 shares made by Eric D. Shaff , and a net sale of 15,855 shares made by Moltke Lisa Von .
In summary, during the past 3 months, insiders sold 30,330 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 30,330 shares. During the past 18 months, 140,004 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 140,004 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
Thomas Desrosier Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Desrosier. You might contact Thomas Desrosier via mailing address: 65 Hayden Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
